logo
  

Kroger Again Boosts FY22 Outlook - Update

While reporting financial results for the third quarter on Thursday, supermarket chain Kroger Co. (KR) again raised its adjusted earnings and identical sales outlook for the full-year 2022.

For fiscal 2022, the company now projects adjusted earnings in a range of $4.05 to $4.15 per share on total identical sales growth, without fuel, of 5.1 to 5.3 percent.

Previously, the company expected adjusted earnings in the range of $3.95 to $4.05 per share on total identical sales growth, without fuel, of 4.0 to 4.5 percent.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $4.08 per share on revenues of $148.11 billion for the year. Analysts' estimates typically exclude special items.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Elon Musk's brain implant firm Neuralink said it has received approval from the U.S. Food and Drug Administration to conduct first-in-human clinical trials. In a tweet, Neuralink said, "We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study! T.W. Garner Food Co. is recalling 50,688 bottles of 12 oz. Texas Pete Buffalo Wing Sauce citing undeclared soy, the U.S. Food and Drug Administration said. The agency noted that some of the bottles may contain Texas Pete Extra Mild Wing Sauce which contains soy. The recall involves Texas Pete Buffalo Wing Sauce with best used by 120623T 065239 UPC 0 75500 10011 6. The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults. Paxlovid (nirmatrelvir tablets and ritonavir tablets, co-packaged for oral use) has been approved to treat adults who are at high...
RELATED NEWS
Follow RTT